Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Street Walker who wrote (2230)	2/10/2000 3:26:00 AM
From: Riverlightning	Respond to of 5582

I agree except for your last point: "4. Save up the $10M for a complete Zicam manufacturing plant to save the $1.50 per box it is currently costing to have manufactured by Botanicals." My problems: Assuming that the $1.50 per box is correct there obviously still would be a cost of doing it themselves. We must know what that cost figures to be to calculate a net savings per box. Then we must have a rough idea of how many boxes we will be making. Then we can estimate total savings. From that point the cost of a new manufacturing plant must be considered. A cost of funds figure on the 10 mil must be subtracted from the total savings. Also, there are likely problems which could result in down time and quality control dropoff as the company switches from one manufacturing facility to another and adjusts to the change. At this time I would say "it ain't broke, don't fix it." Your comments?